- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03413501
A Multi-disciplinary Pain Intervention (MUD-PI) for Patients With Chronic Widespread Primary Pain (MUD-PI)
Study Overview
Detailed Description
The Department of Pain Management and Research at Oslo University Hospital is Norway's largest outpatient pain clinic. It treats around one thousand new patients annually suffering from chronic pain of all aetiologies. Many of the patients receive interdisciplinary care based on a biopsychosocial framework, by at least two health care providers (physician, physiotherapist, psychologist, occupational therapist and/or nurse).
Participants were recruited through referrals from primary or secondary care, which were identified by an established interdisciplinary team. Patients found potentially eligible for the study were contacted by the research team and consulted with a research physician. Patients who fulfilled the inclusion criteria were invited to participate in the study and signed a consent form. Patients who declined to participate and non-eligible patients received usual care.
Inclusion criteria were 1) age 18 or more; 2) pain in at least three out of five bodily regions (defined as the four quadrants and axially); 3) pain persisting three months or more; 4) the patient was able to give informed consent and benefit from group therapy (including sufficient cognitive capacity and language skills); 5) no other medical condition could better explain the symptoms.
Subjects were randomised either to treatment as usual or a group-based multidisciplinary pain intervention (the MUD-PI).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18 or more
- Pain in at least three out of five bodily regions (defined as the four quadrants and axially)
- Pain persisting three months or more
- The patient was able to give informed consent and benefit from group therapy (including sufficient cognitive capacity and language skills
- No other medical condition could better explain the symptoms.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Treatment as usual
Receives treatment as usual at the clinic
|
|
|
Experimental: MUD-PI
Receives multi-disciplinary pain intervention, agroup-based, multi-disciplinary treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Patient generated index
Time Frame: Change in score on inclusion and 1 week after completion of intervention or control group
|
Individualised patient reported outcome
|
Change in score on inclusion and 1 week after completion of intervention or control group
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in EQ-5D
Time Frame: Change in score on inclusion and 1 week after completion of intervention or control group
|
standardised patient reported outcome
|
Change in score on inclusion and 1 week after completion of intervention or control group
|
|
Change in Oswestry disability index
Time Frame: Change in score on inclusion and 1 week after completion of intervention or control group
|
standardised patient reported outcome
|
Change in score on inclusion and 1 week after completion of intervention or control group
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OsloUH Smerteklinikken
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.